HealthcarePapers, 14(3) October 2014: 22-27.doi:10.12927/hcpap.2015.24260
Commentary
Healthcare, Intergovernmentalism and Population Health: The Challenge of Reform in an Era of Disengagement
Abstract
The model proposed by Gardner, Fierlbeck and Levy offers an innovative and compelling framework for moving past the dysfunction of the current intergovernmental relationship in health. It provides a viable role for the federal government and a means to shift our attention on improving health outcomes relative to past provincial performance. At the same time there are important questions about how both federal leadership and population health is understood and justified within the model. The history of federal leadership in health reform is questioned as to both its necessity and its effectiveness. One must also confront the possibility that federal disengagement from contentious intergovernmental issues may be emerging as a more permanent feature of federal–provincial relations in Canada. For the focus on population health to be effective, it must, in the first instance, take into account the necessity of focussing population health interventions for the most marginalized populations and the need to focus those interventions on the socio-economic determinants of health that exist outside of the healthcare system.
This article is for subscribers only.
To view the entire article, sign in if you are a subscriber. Or select one of the options below.
Personal Subscriber? Sign In
Please note: To register for an event you must sign-in as an individual or create a personal Longwood's account. Thank you.
Comments
Be the first to comment on this!
You must sign in to comment Sign In or Create an Account to add comments
Related Content
Nursing Leadership
The Importance of Embedding a Global Perspective Into Canadian Nursing Workforce Policy and Planning
Healthcare Quarterly
Repeated Diagnostic Imaging Studies in Ontario and the Impact of Health Information Exchange Systems
Healthcare Quarterly
Piloting an Outpatient Policy for Funding Drugs and Their Administration in Rheumatology





